Home

Results 1 - 10 of 101,608 for susceptible. Search took 1.169 seconds.  
Sort by date/Sort by relevance
Among 57 countries reporting susceptibility data for extended-spectrum cephalosporins (ESC) (ceftriaxone and/or cefixime), 17 (30%) reported >5% of specimens had decreased susceptibility (Fig 6.2). Among 57 countries reporting on azithromycin susceptibility, 28 (49%) reported >5% resistance (Fig 6.3). (...) Gonococcal antimicrobial susceptibility 6.1 Gonococcal Antimicrobial Surveillance Programme (GASP) 6.2 Antimicrobial susceptibility data 6.3 Data quality and interpretation 7.
Language:English
Score: 942097 - https://www.who.int/reproducti...th/topics/rtis/GASPnetwork.pdf
Data Source: un
Thanks to research generating new evidence, this is the first time that treatment for people with drug-susceptible TB has been shortened to 4 months and shown effective. (...) The  WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment  incorporates all recommendations on the treatment of DS-TB including the standard 6-month regimen. (...) The  WHO Operational Handbook on Tuberculosis,  Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment   provides practical guidance on how to put in place the recommended treatment options at the scale needed to achieve national and global impact.
Language:English
Score: 923068.6 - https://www.who.int/news/item/...dates-in-tb-treatment-regimens
Data Source: un
Susceptibility to marginalization in participatory processes | UNESCO Inclusive Policy Lab Skip to main content UNESCO Inclusive Policy Lab Menu Inclusive Policy Markers Learning E-teams Member search Think pieces Publications Podcasts Expert advice Invite a friend Work by region Quick links About the Lab About the MOST Programme Stay connected           UNESCO.org Log in User login Username or e-mail * Password * Create new account Request new password You are here: Home » Inclusive Policy Markers » Inclusive Policy Markers » Participatory » Transformative participation » Susceptibility to marginalization in participatory processes Susceptibility to marginalization in participatory processes Join Register Ask an expert Explore the inclusive policy markers Join an e-team Invite a friend Step 1 Select a dimension of ex/inclusion Open Multidimensional Relational Intersecting risks and drivers Dynamic Multi-layered and contextual Participatory Selected: Participatory When it comes to inclusion, participation covers the issues of active citizenship, nature of authority and public confidence in state institutions, the role of individuals or groups in public life, and power relations. (...) Step 3 Select a Policy Design Consideration Selected: Susceptibility to marginalization in participatory processes In designing and organizing the process, inclusive policies are sensitive to critiques and risks imbedded in participatory techniques themselves . (...) These factors make them highly susceptible to being marginalized, despite their participation, and to ultimately bearing the brunt of possible trade-offs.
Language:English
Score: 913283 - https://en.unesco.org/inclusivepolicylab/taxonomy/term/215
Data Source: un
Susceptibility to marginalization in participatory processes | UNESCO Inclusive Policy Lab Skip to main content UNESCO Inclusive Policy Lab Menu Inclusive Policy Markers Learning E-teams Member search Think pieces Publications Podcasts Expert advice Invite a friend Work by region Quick links About the Lab About the MOST Programme Stay connected           UNESCO.org Log in User login Username or e-mail * Password * Create new account Request new password You are here: Home » Inclusive Policy Markers » Inclusive Policy Markers » Participatory » Transformative participation » Susceptibility to marginalization in participatory processes Susceptibility to marginalization in participatory processes Join Register Ask an expert Explore the inclusive policy markers Join an e-team Invite a friend Step 1 Select a dimension of ex/inclusion Open Multidimensional Relational Intersecting risks and drivers Dynamic Multi-layered and contextual Participatory Selected: Participatory When it comes to inclusion, participation covers the issues of active citizenship, nature of authority and public confidence in state institutions, the role of individuals or groups in public life, and power relations. (...) Step 3 Select a Policy Design Consideration Selected: Susceptibility to marginalization in participatory processes In designing and organizing the process, inclusive policies are sensitive to critiques and risks imbedded in participatory techniques themselves . (...) These factors make them highly susceptible to being marginalized, despite their participation, and to ultimately bearing the brunt of possible trade-offs.
Language:English
Score: 913283 - https://en.unesco.org/inclusiv...-marginalization-participatory
Data Source: un
Susceptibility to marginalization in participatory processes | UNESCO Inclusive Policy Lab Skip to main content UNESCO Inclusive Policy Lab Menu Inclusive Policy Markers Learning E-teams Member search Think pieces Publications Podcasts Expert advice Invite a friend Work by region Quick links About the Lab About the MOST Programme Stay connected           UNESCO.org Log in User login Username or e-mail * Password * Create new account Request new password You are here: Home » Inclusive Policy Markers » Inclusive Policy Markers » Participatory » Transformative participation » Susceptibility to marginalization in participatory processes Susceptibility to marginalization in participatory processes Join Register Ask an expert Explore the inclusive policy markers Join an e-team Invite a friend Step 1 Select a dimension of ex/inclusion Open Multidimensional Relational Intersecting risks and drivers Dynamic Multi-layered and contextual Participatory Selected: Participatory When it comes to inclusion, participation covers the issues of active citizenship, nature of authority and public confidence in state institutions, the role of individuals or groups in public life, and power relations. (...) Step 3 Select a Policy Design Consideration Selected: Susceptibility to marginalization in participatory processes In designing and organizing the process, inclusive policies are sensitive to critiques and risks imbedded in participatory techniques themselves . (...) These factors make them highly susceptible to being marginalized, despite their participation, and to ultimately bearing the brunt of possible trade-offs.
Language:English
Score: 913283 - en.unesco.org/inclusive...-marginalization-participatory
Data Source: un
New Study 31/A5349 on the treatment of drug-susceptible TB Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) New, shorter and effective treatment regimens for both drug-susceptible and drug-resistant TB are urgently needed to treat all patients with TB and achieve the WHO’s End TB Strategy targets. Therefore, the findings from this study have the potential to complement current options for the treatment of drug-susceptible TB with a new effective and safe 4-month regimen.
Language:English
Score: 913054.9 - https://www.who.int/news/item/...eatment-of-drug-susceptible-tb
Data Source: un
Policy guidance on TB drug susceptibility testing (DST) of second-line drugs (SLD) Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) Thomas The world's leading TB laboratory specialists have issued initial policy recommendations to guide national TB programmes embarking on second-line drug susceptibility testing. The three main objectives of a meeting, hosted by the WHO Stop TB Department, were to develop an interim policy document; update existing technical guidelines; and develop plans for external quality assurance of second-line drug susceptibility testing. (...) The expert group also developed a detailed outline for the update of the 2001 technical guidelines for drug-susceptibility testing of second line drugs, incorporating the newer technologies.
Language:English
Score: 908016.3 - https://www.who.int/news/item/...st)-of-second-line-drugs-(sld)
Data Source: un
Target product profile for next-generation TB drug-susceptibility testing at peripheral sites Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) It is set to steer the research and development arena and encourage the TB community to address diagnostic gaps in a rapidly changing landscape and to enable the development of next-generation drug-susceptibility tests that can be deployed to lower levels of the health system.   (...) “Ensuring that all people with TB have access to universal drug-susceptibility testing  is a critical element in our fight to end TB,” said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme.
Language:English
Score: 906779.6 - https://www.who.int/news/item/...tb-drug-susceptibility-testing
Data Source: un
Update of the WHO guidance on the treatment of drug susceptible tuberculosis Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) Drug susceptible TB affects approximately 7 million people annually. (...) WHO last updated its guidance on the treatment of drug susceptible TB in 2017 . At this time WHO issued a recommendation against the use of shorter fluoroquinolone containing regimens as the evidence did not support that these regimens were more effective than the six-month regimen.
Language:English
Score: 906779.6 - https://www.who.int/news/item/...-drug-susceptible-tuberculosis
Data Source: un
Since the early 1990s, WHO has produced a series of guidelines for effective treatment of drug-susceptible and drug-resistant TB, including recommendations regarding the need for drug resistance surveillance and drug susceptibility testing for good clinical and epidemiological practice. (...) The quality of the susceptibility tests carried out in this laboratory should be regularly checked by another reference laboratory at national or supranational level." (...) In 2001, the first attempt to standardize international methodology for second-line drug susceptibility testing was presented in the WHO guidelines for drug susceptibility testing for second-line anti-TB drugs for DOTS-Plus (subsequently updated).
Language:English
Score: 904777.6 - https://www.who.int/news/item/...ho-and-the-emergence-of-xdr-tb
Data Source: un